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E-mail address: tobias.maier@crg.es (T. Maier).The correlation between mRNA and protein abundances in the cell has been reported to be notori-
ously poor. Recent technological advances in the quantitative analysis of mRNA and protein species
in complex samples allow the detailed analysis of this pathway at the center of biological systems.
We give an overview of available methods for the identiﬁcation and quantiﬁcation of free and ribo-
some-bound mRNA, protein abundances and individual protein turnover rates. We review available
literature on the correlation of mRNA and protein abundances and discuss biological and technical
parameters inﬂuencing the correlation of these central biological molecules.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction The increasing amount of available large-scale high-qualityThe acquisition and interpretation of large quantitative data-
sets across multiple samples is a major challenge for systems biol-
ogy. Systems biology aims for the discovery and understanding of
newly emerging properties arising from a global, systemic angle
of analysis. Ultimately, systems biology intends to reproduce bio-
logical systems in terms of mathematical models and simulations,
deriving biologically meaningful conclusions there from. Systems
biology crucially depends on the accurate quantitative description
of complex biological samples. It makes use of large-scale data-sets
often derived from genomics and proteomics analyses and requires
determination of concentrations, binding constants and interac-
tions. For some time many groups have used data regarding
changes in gene expression as evidence of consequent changes in
protein expression. However, this is not always necessarily the case.
The central dogma of molecular biology deals with the transfer
of information from DNA via mRNA to proteins. It is mechanisti-
cally very well understood how genes get transcribed, mRNA gets
processed and sequentially translated into amino acid chains at the
ribosome and subsequently fold into functional proteins. However,
most reports on mRNA and protein abundances ﬁnd only a weak
correlation between the respective abundances of these two
classes of biological molecules. Several biological factors were
identiﬁed which inﬂuence this correlation, but also methodological
constraints play a role when comparing mRNA to protein levels.chemical Societies. Published by Equantitative data-sets for both mRNA and proteins resulting from
genomics and proteomics experiments should allow the accurate
analysis of this physiological phenomenon observed for years but
not readily accessible experimentally until now. Methods for the
global identiﬁcation, quantiﬁcation and analysis of the transcrip-
tome and the translatome in biological samples have rapidly im-
proved over the last years, but still demand a high level of
expertise both experimentally and computationally.
In course of this review, we will present an overview over avail-
able techniques to quantify mRNA and proteins in complex biolog-
ical samples. We review available mRNA–protein correlation
studies and comment in detail on technical and biological factors
inﬂuencing the quantitative relation between mRNA and protein.
2. Methodology for the quantitative analysis of mRNA and
proteins in complex samples
2.1. mRNA
Transcript and protein tracking systems have offered an unprec-
edented view of inner workings of cells. Mechanisms that regulate
the synthesis, processing, transport, translation and stability of
mRNAs are critical points in cell function. The ability to measure
RNAs is providing a more accurate view of gene expression. Classi-
cal methods such as Northern blotting and RT-PCR allowed the
steady state measurement of selected transcripts. Recent methods
provide a wider scope of possibilities. Next-generation sequencing
methods provide with the mapping and quantiﬁcation of severallsevier B.V. All rights reserved.
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arrays and Affymetrix chips are still the most used tools to mea-
sure mRNA levels [1,2], they are progressively being replaced by
deep sequencing technologies. On the other hand, accurate
description of concrete pathways can be achieved in vivo at single
cell resolution.
2.1.1. High-throughput measurements
The high throughput of next-generation sequencing technology,
rapidly producing huge numbers of short sequencing reads, made
possible the analysis of a complex sample containing a mixture
of different transcripts. However, expression microarrays are still
probably the most widely used methodology for transcriptome
analysis. They consist of a large number of clusters of molecules
of DNA called probes distributed in rows on a surface. One probe
or subgroups of them are designed to hybridize with a concrete
transcript. Microarrays permit to monitor the expression of tran-
scripts with complementarity to the probes. They can be used to
measure absolute transcript concentrations whenever the probe
binds to its target speciﬁcally [3]. For estimating transcript concen-
trations a proper calibration is required. Although having been
extensively used they rely in sequence-speciﬁc probe hybridiza-
tion, suffer from background and cross-hybridization problems
[4,5], dye-based detection issues and design constrains that seri-
ously limit the detection of RNA splice patterns or unknown genes.
More recently, whole-genome tiling arrays have been also used for
measuring gene expression or new gene discovery. These arrays
differ from microarrays in the nature of the design. Probes are tar-
geted to cover the entire genome and not only the annotated tran-
scripts. These speciﬁc arrays can discover new exons but still
conserve the rest of microarrays limitations. In contrast, tag-based
methods like SAGE (Serial Analysis of Gene Expression) measure
absolute abundances and are not limited to array content. They
can provide precise digital gene expression levels but only a por-
tion of the transcript is analyzed making splice isoforms not
distinguishable.
Recently, the possibility to use next-generation sequencing
methods for mapping and quantifying transcriptomes has been re-
ported [6]. Novel sequencing techniques provide high speed and
throughput. RNA is transformed to cDNA and ampliﬁed. Determi-
nation of sequence data can be achieved with a massive sequence
parallelization using different techniques [7]. Sequences produced
using RNA-seq [8] are aligned to the genome and the different
transcripts are quantiﬁed in reads per kilobase of exon model per
million mapped reads (RPKM) [6]. The RPKM measure is related
to the molar concentration of the transcript in the starting sample
which may be used for comparison of transcript levels within and
between samples. With the use of spike in RNA, absolute transcript
levels can be calculated. A 40-million-read transcriptome data-set
provides reliable measurement of a single transcript per cell in
human cell lines. Owing to the massive number of sequences,
low-abundance RNAs can be detected. With this technique, tran-
scripts are characterized through their sequence avoiding the lim-
itation to known transcript products. One of the most attractive
advantages of deep sequencing methods is the ever decreasing
cost. The different advances in the ﬁeld have led to an exponential
reduction in cost per base. An inconvenience is the cost of acquir-
ing the necessary equipment. However, when considering the price
per sequenced base, it is already in most of the cases, much less
expensive than microarray-based methods.
2.1.2. Single cell in vivo measurements
Individual native RNA molecules can be visualized in vivo. By
labeling RNAs with stem loop repeats from the MS2 bacteriophage,
which will bind to a GFP-tagged MS2-coat-protein product con-
struct, one can examine the dynamics of speciﬁc RNAs in singlecells [9]. This ability to measure has provided important details
of how transcription is carried out in pulses [10–12]. The MS2-
based technology can be embedded in a system that allow all the
components involved in gene expression (DNA, RNA, protein) to
be visualized in real time [13]. This system combines lac-repres-
sor-operator and MS2-coat-protein-translational operator interac-
tion units and tetracycline response elements. It allows an in vivo
direct tracking of gene expression but it is limited to a subset of
transcripts since it needs speciﬁc labeling for each of them.
2.2. Protein
2.2.1. 2D SDS–PAGE coupled to mass spectrometry (MS)
Traditionally, individual protein expression levels in complex
samples are analyzed by two-dimensional sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (2D SDS–PAGE). The
methodology involves an isoelectric focusing step along an immo-
bilized pH gradient and subsequent separation of the proteins by
SDS–PAGE. Obtaining reproducible gels by two-dimensional gel
electrophoresis is technically demanding and often complicates
the comparison of gels from different samples prepared under sim-
ilar conditions. Very basic and acidic proteins, very large and very
small proteins, as well as low abundant species are often hard if
not impossible to analyze by 2D SDS–PAGE [14,15].
Different visualization techniques exist for SDS–PAGE separated
proteins. Classical protein staining methods are either not sensitive
enough (Coomassie blue) or not quantitative over a wide range of
spot intensities (silver staining) to directly infer protein abundance
levels from the protein spots [16,17]. Alternative staining methods
with ﬂuorescent dyes overcome several problems. Difference Gel
Electrophoresis (DIGE) is more sensitive and allows the quantita-
tive analysis of protein spots on 2D gels over a wide dynamic range
[18,19]. Because several samples can be separated on the same gel,
the direct comparison between different samples is greatly
facilitated.
Separation of proteins by 2D SDS–PAGE and quantiﬁcation of
the spots using suitable dies merely requires their subsequent
identiﬁcation by mass spectrometry to assign quantitative infor-
mation to individual proteins. Small gel pieces corresponding to
individual gel spots are excised with suitable tools and the sepa-
rated proteins are digested with trypsin and identiﬁed either by
peptide mass ﬁngerprinting or tandem MS.
2.2.2. Quantitative MS technologies
In recent years, mass spectrometry techniques for the identiﬁ-
cation and quantiﬁcation of complex biological samples have ad-
vanced tremendously [20,21]. Sample complexity is reduced by
separating digested protein mixtures by liquid chromatography
prior to on-line electrospray ionization and subsequent mass spec-
trometric analysis of the isolated peptides. Several mass spectrom-
eter designs exist, each with speciﬁc advantages for mass accuracy,
dynamic range, resolving power and sensitivity [22]. Hybrid
instruments, such as the LTQ-Orbitrap machines combine high
mass accuracy, high resolving power and a high dynamic range
[23]. Selected reaction monitoring (SRM) on a hybrid triple quadru-
pole/ion trap mass spectrometer recently allowed the identiﬁca-
tion and quantiﬁcation of low-abundance proteins in a whole cell
lysate of Saccharomyces cerevisiae [24].
Mass spectrometry on protein samples is intrinsically not quan-
titative. However, several methods have been developed to over-
come this problem. They basically fall into two groups:
quantiﬁcation using stable isotope labeling and label free quantiﬁ-
cation. Stable isotope labeling of peptides can be achieved either by
metabolic labeling of intact proteins during cell culture (e.g. SILAC
[25]) or by chemical labeling of peptides after tryptic digestion (e.g.
ICAT, iTRAQ [26,27]). The SILAC method has been used to quantify
Table 1
Overview of mRNA–protein correlation studies in different organisms. rp: Pearson
correlation coefﬁcient and rs: Spearman rank coefﬁcient. Data-set size refers to the
number of mRNA–protein pairs used for the determination of respective correlation
coefﬁcients.
Organism rp rs Data-set size Reference
Saccharomyces cerevisiae 0.36 n.d. 73 [40]
Saccharomyces cerevisiae 0.76 0.74 148 [39]
Mus musculus 0.59 n.d. 425 [46]
Saccharomyces cerevisiae n.d. 0.45 678 [43]
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embryonic stem cells [28,29].
Label-free quantiﬁcation of proteins relies on information ob-
tained directly from mass spectrometer read outs. A simple meth-
od involves counting and comparing the number of fragment ion
spectra of a given peptide. This method is based on the ﬁnding that
the MS/MS sampling rates for particular peptides are directly re-
lated to the abundance of a peptide represented by its precursor
ion in the sample. Typically the 1–5 most intense precursor ions
per protein are used for quantiﬁcation [30,31]. A slightly different
approach is the protein abundance index (PAI) [32]. Here the num-
ber of identiﬁed peptides in an MS/MS run are set in relation to the
number of theoretically observable peptides for each protein. Pro-
teins can also be quantiﬁed by measuring and comparing peptide
precursor ion signal intensities integrated over their full retention
time [33]. This latter method relies on the alignment of chromato-
grams and often requires very speciﬁc software. In contrast to the
stable isotope, label-free quantiﬁcation relies more heavily on
technical replicates.
While the aforementioned methods give mostly relative quanti-
tative information between two, or several, protein samples, re-
cently approaches were developed allowing for the absolute
quantiﬁcation of entire proteomes. The absolute quantiﬁcation
(AQUA) of proteins by mass spectrometry involves spiking known
amounts of synthesized, stable isotope labeled peptides mimicking
expected tryptic peptides into the digested protein sample [34].
The labeled peptides serve as an internal standard. They behave
identical as their native counter parts in liquid chromatography
prior to MS, since they have the same chemical properties. How-
ever, the heavy isotope label, leads to a mass shift which can be de-
tected by mass spectrometry. Integration of respective peak areas
and comparison between labeled and unlabeled isoforms allows
the absolute quantiﬁcation of the corresponding protein. Combin-
ing the AQUA technique with label free quantiﬁcation approaches
allows the absolute quantiﬁcation of proteins in complex mixtures
[35]. A recent article reports the ﬁrst example of the absolute
quantiﬁcation of an entire proteome in the model organism Lepto-
spira interrogans, making use of this combinatorial approach [36].
2.2.3. Alternatives for measuring protein abundance
Alternative, non MS-based methods exist to for the quantiﬁca-
tion of individual proteins in complex samples. They involve
in vivo tagging of proteins with detection markers. Namely the
TAP-tag (tandem afﬁnity puriﬁcation) and fusion of cellular pro-
teins with the green ﬂuorescent protein (GFP) lead to global mea-
surements of protein abundance in cells [37,38]. TAP-tagged
proteins are analyzed by Western blotting and GFP fusion proteins
can be quantiﬁed by ﬂow cytometry, even on the single cell level.
Both approaches correlate well (r2 = 0.80) [38]. Again, relating the
relative or abstract quantities derived from these techniques to
suitable standards with known concentrations allows the absolute
quantiﬁcation of all identiﬁed species in a given sample. For exam-
ple quantitative Western blotting with puriﬁed proteins as stan-
dards can be used [38].
However, tag-based quantiﬁcation of proteomes is very work-
intensive and interference of the tag with protein expression, sta-
bility and function cannot be excluded. Also, perhaps more impor-
tantly, genome-wide tagging approaches are only applicable to
organisms with established protocols for genetic manipulation in
a high-throughput format.Desulfovibrio vulgaris 0.50 n.d. 703 [45]
Escherichia coli 0.57 0.50 1103 [32]
Schizosaccharomyces pombe 0.58 0.61 1367 [44]
Saccharomyces cerevisiae 0.66 n.d. 2044 [41]
Saccharomyces cerevisiae n.d. 0.57 4251 [38]
n.d.: not determined.3. Available data on mRNA protein correlation
Published studies on the correlation of mRNA and correspond-
ing protein levels in complex samples are not very abundant. Theyfocus mostly on yeast species, involving sub-sets of the genome
and proteome accessible by the respective experimental tech-
niques. Also few studies on mRNA–protein correlations in bacteria
and mammalian cells have been published. It has been shown that
protein and mRNA abundances are not following a normal distri-
bution [38,39]. Therefore the Spearman rank coefﬁcient (rs) is more
suitable than the Pearson correlation coefﬁcient (rp) to describe the
correlation between mRNA and protein levels. However, both cor-
relation methods give similar results and they are used equiva-
lently in available publications on mRNA–protein correlations. A
summary of available publications on the correlation of mRNA
and protein abundances in complex samples is given in Table 1.
Gygi et al. [40] compared mRNA and protein levels for 106 yeast
proteins. The authors relied on serial analysis of gene expression
(SAGE) tables for mRNA levels. Protein spots were excised from
2D gels and quantiﬁed metabolically labeling the cells with 35S-
methionine and scintillation counting. They found a 20–30-fold
difference in expression levels and overall weak correlation. High
expression level was indicative of better correlation values. Their
analysis contained a systematic experimental error for the protein
identiﬁcation and quantiﬁcation. Only proteins with high codon
bias and long predicted half-life were present in the analyzed
data-set.
Futcher et al. [39] followed a similar methodology, albeit ﬁnd-
ing a better correlation between mRNA and protein abundance
(rp = 0.76, rs = 0.74). Their identiﬁed proteins also had a high codon
bias, when compared with the theoretical distribution of the yeast
genome. Their results indicated a good correlation between the Co-
don Adaptation Index (CAI) and protein abundance. Protein turn-
over data showed that, similar to [40] only proteins with long
half-lives were accessible by the employed methodology involving
2D SDS–PAGE.
Greenbaum et al. [41] integrated these and other studies on
protein abundance in yeast. Their reference data-set containing
2044 proteins showed a good correlation between mRNA and pro-
tein levels (r = 0.66). The authors looked at the correlation of mRNA
and protein abundance for genes with either variable or steady lev-
els of mRNA along the yeast cell cycle. They found that varying
mRNA levels correlated well with corresponding protein levels
(rp = 0.89), whereas genes expressed at steady levels had ﬂuctuat-
ing protein levels along the cell cycle (rp = 0.2). The authors also
showed that high ribosomal occupancy (that is the fraction of
mRNA bound to ribosomes at any given time) for mRNA resulted
in a better correlation with protein levels, as compared to uncorre-
lated mRNA and protein levels when respective mRNA species
showed low ribosomal occupancy.
A study using ICAT reagents for relative quantiﬁcation of pro-
teins monitoring fold changes revealed varying degrees of correla-
tion between mRNA and protein levels in yeast in response to
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proach with metabolically labeled yeast samples lead to the iden-
tiﬁcation and quantiﬁcation of 678 yeast proteins. The correlation
with microarray data from identical samples was reported as
weakly positive (rs = 0.45) [43]. Label-free quantiﬁcation of the
Schizosaccharomyces pombe proteome by spectral counting allowed
the comparison of 1367 mRNA–protein pairs. Determined correla-
tion coefﬁcients were rs = 0.61 and rp = 0.58, respectively [44].
Correlation of protein abundances determined by immuno-
staining for 4251 individually TAP-tagged yeast strains with pub-
lished microarray data was similarly shown to be weakly positive
(rs = 0.57) [38]. In a correlation study between mRNA and protein
abundance in the bacterium Desulfovibrio vulgaris [45] similar cor-
relation coefﬁcients were observed, indicating that the reported
weakly positive correlations are not limited to yeast cells but also
extend to prokaryotic organisms. Ishihama et al. used the Codon
Adaptation Index (CAI, see below) as a measure for gene expression
and found correlation coefﬁcients of rs = 0.50 and rp = 0.57, respec-
tively, in Escherichia coli [32]. A study in two hematopoietic mouse
cell lines revealed similar correlation coefﬁcients for mammalian
cells (rp = 0.59, 425 mRNA–protein pairs) [46].
A software package called PARE (Protein Abundance and mRNA
Expression) has been published which allows the rapid assessment
of mRNA–protein correlation for complex samples. Data-sets for
yeast, rat, mouse and Halobacterium are provided, but own quan-
titative results can be uploaded for analysis [47].
The available body of literature shows that the correlation of
mRNA and protein levels in complex samples is far from perfect.
This ﬁnding points towards complex and divers regulatory mecha-
nisms responsible for the observed differences in the quantitative
relation between transcriptome and translatome. Several reasons
can be causative for the apparent poor correlation: (1) post-tran-
scriptional parameters; (2) post-translational parameters; and (3)
noise and experimental error. Speciﬁc mechanisms from these top-
ics are discussed in the following paragraphs.4. Parameters inﬂuencing mRNA–protein correlation
Transcription and translation are far from having a linear and
simple relationship. Different mechanisms involving cis-acting
and trans-acting mechanisms generate a big repertoire of systems
that enhance or repress the synthesis of proteins from a certain
copy number of mRNA molecules. Different events may uncouple
transcription and translation continuously or under certain
conditions.
4.1. RNA secondary structure and Shine Dalgarno sequence differences
The physical transcript properties modify translation efﬁciency
at different levels. Prokaryotic protein coding transcripts may have
a speciﬁc ribosomic binding site upstream of the start codon. It is
complementary to 30end of the 16S rRNA and it is called Shine Dal-
garno (SD) sequence. Rate of translation is dependent on the SD se-
quence. Transcripts with a weak SD (not perfect complementarity
to rRNA) sequence are translated with lower efﬁciency. This effect
already adds some complexity, since not all RNAs are translated
into proteins equivalently.
In addition, other condition dependent features of the mRNA
such as RNA structure may change under certain conditions trans-
lation efﬁciency. Base-paired structures in the mRNA can selec-
tively sequester and expose the ribosome binding site. For
instance, secondary and tertiary interactions involved in mRNA
folding are sensitive to temperature. Temperature dependent
structural changes may distinguish translationally active and inac-
tive mRNA structures. A well studied example is rpoH mRNA inE. coli. It acts as a thermostat, at low temperatures rpoH mRNA is
stably folded in a conformation that prevents 30S subunit associa-
tion but upon heat shock induction it unfolds enough to be trans-
lated [48]. Conformational changes in the mRNA can be also
induced by small metabolites. For example, translation of the
mRNA encoding the cobalamin-transport protein (btuB) in E. coli
is repressed at high coenzyme B12 concentration [49].
4.2. Regulatory proteins
Regulatory proteins and sRNAs can act as translational modula-
tors. For instance, in E. coli, genes encoding R-proteins (rpl, rps) are
spread in several operons. A regulatory R-protein represses trans-
lation of some cystrons by binding to its own mRNA at a region
contiguous with the SD sequence [10]. The target RNA sites are
similar to their corresponding binding sites in the rRNA but with
a lower afﬁnity. Only when all rRNA is assembled into ribosomes,
R-proteins bind to their mRNA so as to stop translation.
4.3. Regulatory sRNAs
It is clear now that sRNAs have a key regulatory role in regulat-
ing gene expression in prokaryotes. They are known to inﬂuence
the evolution and stability of mRNAs but they can also affect trans-
lation efﬁciency. Different mechanisms have been described. Some
promote ribosome binding [50] to the target mRNA whereas others
block translation [50]. Quantitative analysis of the mechanisms re-
vealed sRNA higher capacity to ﬁlter noise from input signals and
the ability to respond fast to big input signals to modify speciﬁc
protein concentrations [51]. In many cases, sRNAs introduce com-
plexity in the mRNA protein relationship. In E. coli, translation inhi-
bition of galactokinase (third cystron of the lac operon) is carried
out by a sRNA called spot 42. It binds to the SD sequence in galK
RNA inhibiting translation [52]. Also examples of translation acti-
vation have been reported. For example, in Staphylococcus aureus
a sRNA called RNAIII controls the expression of toxin genes (hla).
The 50 UTR of hla mRNA containing the SD sequence forms a sec-
ondary structure by base-pairing with a upstream cis-acting se-
quence and therefore blocking translation. RNA III binds with
such a cis-acting element avoiding translation inhibition [53].
4.4. Codon bias and codon adaptation index
In many organisms, synonymous codons (i.e. coding for the
same amino acid) are used with different frequencies. This phe-
nomenon is called codon bias. A sophisticated measure for the co-
don bias is the codon adaptation index (CAI) [54]. It is based on a
test set of highly expressed genes and considers the relative adap-
tiveness of each gene. The CAI for an individual gene g is deﬁned
as:
CAIg ¼
YN
i¼1
w1=Ni ;
where N is the number of codons in gene g and wi is the relative
adaptiveness of codon i [55].
It has been shown that a large codon bias correlates with highly
expressed genes [56,57] and proteins [55,58]. The codon bias is be-
lieved to be mainly a mechanism by which the cell can maximize
translation efﬁciency. Determining the codon bias distribution for
identiﬁed proteins from organism-wide proteomics studies and
comparing it to the calculated bias distribution of the respective
genome therefore gives information on the experimental coverage
of low abundant proteins [40]. A comparative study showed that
the codon bias has a higher inﬂuence on mRNA–protein correlation
than sequences upstream of the translation initiation site (Shine
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showed that the speciﬁc codon usage contributes to 8.9% of the to-
tal variation in mRNA–protein correlation [60].
4.5. Ribosomal density and ribosome occupancy
The translational efﬁciency is the number of completed protein
molecules produced per mRNA and time [61]. One measure for
translational efﬁciency is the ribosomal density (i.e. the number
of ribosomes per transcriptional unit) or the ribosome occupancy,
which denotes the speciﬁc enrichment of individual mRNA species
on ribosomes. Different translation efﬁciencies for mRNA mole-
cules directly inﬂuence the mRNA–protein correlation. Ribosome
occupancy can be determined by obtaining polysome proﬁles by
sucrose gradient centrifugation [61], afﬁnity tag puriﬁcation [62]
and subsequent microarray analysis and/or Northern blotting [1]
as well as by deep sequencing of ribosome protected mRNA frag-
ments [63] (Fig. 1).
Translation efﬁciency is highly diverse both quantitatively and
qualitatively and no linear relationship between mRNA abundance
and individual protein synthesis rate can be assumed [61]. Results
on exponentially growing yeast cells showed that mRNA speciesFig. 1. Central pathway of molecular biology, experimental techniques to measure mR
correlation. Sequencing approaches are used to measure free and ribosome-bound mRN
cellular proteins and their individual turnover rates.can have different numbers of ribosomes attached, indicating high-
er translation rates with more ribosomes attached [1]. It is esti-
mated that roughly one third of expressed genes are
translationally regulated [63]. A quantitative comparison of ribo-
some attached mRNA to corresponding free mRNA fragments re-
vealed a roughly 100-fold range of translation efﬁciency,
additionally to a translationally inactive fraction of identiﬁed tran-
scripts [63]. The fraction of ribosome-associated mRNA molecules,
indicating actively translated species is thought to be a better pre-
dictor of protein abundance than mRNA abundances alone. Indeed,
Ingolia et al. showed that numbers for ribosome-associated mRNA
correlated signiﬁcantly better than mRNA abundance alone with
absolute protein levels [63].
In yeast, transcripts with high occupancy correlate better with
their corresponding protein abundance [41] and very long tran-
scripts showed on average a lower ribosomal density than shorter
mRNAs [1,61]. Ribosomes are approximately three fold enriched on
the ﬁrst 30–40 nucleotides of protein coding sequence [63]. This
ﬁnding can be attributed to either a slow translational start or to
premature translation termination. A recent study in yeast showed
a highly correlated response to cellular stress between actual tran-
scripts and ribosome-associated mRNA [64].NA and protein at various stages and parameters inﬂuencing the mRNA–protein
A. Mass spectrometry based methods allow the identiﬁcation and quantiﬁcation of
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correlation at least for a subset of genes [1,63]. A multiple regres-
sion analysis of different biological factors inﬂuencing the mRNA–
protein correlation in yeast estimated the contribution of ribosome
occupancy and ribosomal density to be around 5% of the total var-
iation [60].
4.6. Protein half-lives
The major post-translational factor inﬂuencing mRNA–protein
correlation is the individual half-life of proteins. The cellular life-
time of a protein depends on several factors: intrinsic protein sta-
bility, the ﬁrst amino-terminal amino acid (N-end rule), post-
translational processing, such as phosphorylation, and ubiquitina-
tion, and on the localization of the respective protein. Protein half-
lives are highly variable, ranging from a few seconds to several
days. A prediction algorithm based on protein and mRNA abun-
dance, ribosome density and occupancy and transcript length pro-
vided theoretical half-lives ranging over ﬁve orders of magnitude
[65]. Correlation analysis of various parameters showed that pro-
tein turnover, estimated by this protein half-life descriptor is the
most important biological parameter inﬂuencing mRNA–protein
correlation [60]. A somewhat simpler and probably less accurate
method to estimate individual protein half-lives can be applied
by following the N-end rule [66], based on the ﬁnding that the
dominant feature governing the turnover of a speciﬁc protein is a
destabilizing N-terminal residue. The N-end rule and associated
mechanisms have been shown to be active in E. coli, S. cerevisiae
and mammalian cells. Although prokaryotes and eukaryotes use
different strategies for degradation of N-end rule substrates, recent
ﬁndings indicated that they share common principles of substrate
recognition [67].
Protein half-lives can be determined by different labeling strat-
egies. Pulse-chase experiments involving metabolic labeling of
cells with radioactive methionine have traditionally been used to
measure global protein turnover. Identiﬁcation of labeled proteins
from 2D gels allows for the determination of individual protein
half-lives [68]. However, application of the N-end rule to protein
samples separated by 2D gels and identiﬁed by mass spectrometry
revealed a bias for detected proteins to have high turnover times
[40]. Concurrent with the recent advances in mass spectrometry,
stable isotope labeling approaches have been developed to deter-
mine individual protein turnover rates [68,69] (Fig. 1). A corre-
sponding approach has recently been used to determine the
turnover rates of nearly 600 proteins from a human cell line [70].
Further advances in these mass spectrometry based approaches
should yield proteome-wide data on individual protein turnover
rates. Benchmarking and integration of this type of data with cur-
rent prediction algorithms is necessary to obtain a more accurate
picture of the biological factors inﬂuencing mRNA–protein
correlation.
4.7. Other biological factors inﬂuencing mRNA–protein correlation
Several other factors have regulatory function for gene expres-
sion and protein synthesis. Absolute ribosome abundance globally
regulates translation efﬁciency, but has not individual impact on
the mRNA–protein correlation. The speciﬁc amino acid usage for
protein synthesis has been reported to contribute to 7–8% of the
overall variation in Desulfovibrio and yeast [60,71]. Minor effects
are attributed translation initiation, start codon, stop codon and
stop codon context [59,71].
Other, perhaps more important features to be considered and
possibly responsible for signiﬁcant outliers are untranslated RNA
species, as well as secreted proteins escaping identiﬁcation by
mass spectrometry. In eukaryotic cells mRNA distribution andsequestration to compartments such as the nucleus also inﬂuences
the translation rate.
4.8. Experimental error and noise
Gene expression is composed by several stochastic steps involv-
ing species acting at very low concentration. These properties
make it especially difﬁcult to monitor. Some microarrays based
experiments have been used successfully in different systems to
measure down to the level of two copies per cell in yeast [72]. Sim-
ilar results have been found for other systems and platforms
[73,74]. Although RNA-seq has improved the signal to noise ratio,
it is not completely free of ambiguity. However, methods for tran-
script quantiﬁcation are reproducible and sensitive. Some methods
offer reliable quantiﬁcations in a broad range of concentrations
spanning four orders of magnitude [6]. Also it provides a better
accuracy than microarrays. A 40-million-read transcriptome
data-set provides reliable measurement of a single transcript per
cell in human cell lines [6]. A comparison with ﬁve array platforms
demonstrates a better resolution, reproducibility and robustness of
a deep sequencing based method [75].
Noise is a prevalent feature of biological systems. For example,
studying protein levels on a single cell level by GFP tagging of indi-
vidual ORFs revealed strong protein speciﬁc differences regarding
abundance and function [37]. Besides noise on a single cell level
and the biological factors described above, experimental error is
signiﬁcantly contributing to the observed variation of the correla-
tion of mRNA and proteins. Nie et al. [45] analyzed global mRNA
and protein levels in the bacterium D. vulgaris. Their multiple
regression analysis showed that the analytical variation in protein
abundance contributed to 34–44% of the total variation observed.
However, this value cannot be generalized to other analyses; espe-
cially recent advances in quantitative mass spectrometry tech-
niques should signiﬁcantly yield lower error rates for
translatome measurements. For example, Silva et al. reported an
error of ±15% in an absolute quantiﬁcation study using the average
MS signal intensities for the three most abundant peptides per
protein as quantitative measure and subsequent normalization to
isotopically labeled peptides as internal standards [35]. For a
proteome-level comparison of two cell lines, Pan et al. reported a
very high accuracy and reproducibility for the quantiﬁcation of
4000 proteins. The Pearson correlation coefﬁcient between biolog-
ical replicates was rp = 0.95 [76].
The total error for quantitative characterization of complex
samples using mass spectrometry is difﬁcult to evaluate. Several
experimental and technical sources, as well as data processing is-
sues contribute. In elaborate large-scale MS studies typically few
biological replicates are studied, mainly because data analysis is
very time-consuming but also for reasons of machine availability.
Sample processing and quantitative recovery of digested peptides
can be a source of experimental error. Differences in liquid chro-
matography separation, peptide ionization and equipment varia-
tion complicate the comparison between two different MS-setups
[77].
MS data analysis itself requires several steps, such as baseline
adjustments, data normalization and ﬁltering, peak detection and
quantiﬁcation, the application of error models and statistics analy-
sis [78]. Key to the error evaluation of complex proteomics data-
sets are threshold criteria for peptide identiﬁcations. Raising the
required identiﬁcation scores reduces the number of false positive
identiﬁcations, while at the same time increasing the false negative
rate [79]. Researchers are well aware of this signal to noise prob-
lem and other error sources, such as sequence data base bias, when
interpreting mass spectrometric data and sophisticated experi-
mental and statistical methods exist to evaluate and minimize
the technical error due to MS analysis [80,81].
3972 T. Maier et al. / FEBS Letters 583 (2009) 3966–3973Recently signiﬁcance analysis of microarray data (SAM) has
been adapted to quantitative proteomic data. SAM assigns a signif-
icance value, a false positive and false negative rate for differential
expression of individual proteins. Such information is not readily
available by conventional t-test or fold change test alone [82]. A
large variety of MS data analysis software packages exist, also com-
prising statistical tools for data analysis (for an overview see
[81,83–85]).
5. Concluding remarks and outlook
The correlation between mRNA and protein abundance depends
on various biological and technical factors. To quantify their
respective inﬂuence, multiple regression analysis has proven use-
ful [45,60]. While some of these factors can be directly determined
from available sequence data, such as RNA secondary structure, co-
don bias and amino acid usage, others need to be determined
experimentally, such as mRNA abundance, ribosome occupancy,
protein abundance and turnover. Fig. 1 gives an overview of the
central pathway of molecular biology and schematically shows
current approaches to determine these factors experimentally.
It is difﬁcult to evaluate on a global level which biological factor,
translation efﬁciency or protein half-life, most prominently inﬂu-
ences the correlation between mRNA and protein abundances. In
yeast, one third of all transcripts appear to be regulated transla-
tionally with roughly a 100-fold rage of translation efﬁciency
[63]. Individual protein half-lives range from several seconds to
tens of hours [70], a more than 1000-fold range. Hence protein
turnover is probably inﬂuencing the correlation between mRNA
and protein abundances to a greater degree. Studies on individual
protein turnover rates on an organism-wide level appear within
reach with current technical advances in mass spectrometry apply-
ing labeled isotope techniques.
In general, the recent advances in mass spectrometry-based
protein quantiﬁcation techniques with low experimental error
and high accuracy in quantiﬁcation, and quantitative deep
sequencing methods for mRNA should help in future analyses to
give a more accurate picture of the organism-wide correlation be-
tweenmRNA and protein and the inﬂuence of respective modifying
parameters. Analyses of samples from the same biological system
under various conditions, such as response to cellular stresses or
analysis at different stages of the cell cycle should yield speciﬁc
physiological information derived from the –omics analysis of
complex biological samples.
Future challenges lie in data base development and the compu-
tational integration of –omics data-sets from different sources,
allowing for example the seamless mapping of identiﬁed proteins
to corresponding mRNA data [86]. Also the correct assessment of
technical and experimental errors is crucial for the meaningful
interpretation of integrative studies, such as on the correlation of
mRNA and protein abundances. Solid statistical methods embed-
ded in a larger framework need to be established, to allow mean-
ingful conclusions from comparative studies on large data-sets.
Systems biology crucially depends on the availability of large-
scale high-quality quantitative data-sets. Therefore this thriving
new ﬁeld in biology is intimately related to the advancement of
–omics methods. The example of mRNA–protein correlation shows
how accurate data-sets help to identify and quantify biological fac-
tors inﬂuencing this central pathway.
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